Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension.
R
R
Ilsar
J
J
Levitt
M K C
MK
Ng
L
L
Kritharides
M R
MR
Adams
D S
DS
Celermajer
D000109:Acetylcholine / Q000627:therapeutic use; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001120:Arginine / Q000627:therapeutic use; D000077300:Bosentan; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy; D008168:Lung / Q000000981:diagnostic imaging / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D013449:Sulfonamides / Q000627:therapeutic use*; D014463:Ultrasonography; D019323:omega-N-Methylarginine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D013449:Sulfonamides; D009599:Nitroprusside; D019323:omega-N-Methylarginine; D001120:Arginine; D000109:Acetylcholine; D000077300:Bosentan